Clin2
NCT07619989Possibly a fitRecruiting

Ear nerve stimulation for weight loss after tirzepatide

Obesity & Overweight

Part of Hormones & metabolism clinical trials.

This trial tests if a gentle electrical stimulation to the ear can help people who haven't lost much weight with tirzepatide (a diabetes/weight drug). It's for people who are still overweight after 12 weeks of treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
24 people
Ages
18 years to 50 years
Study type
Interventional

Who can take part

  • You are overweight or obese and have a weight-related health issue like high blood pressure or fatty liver.
  • You have been taking tirzepatide for at least 12 weeks but lost 10% or less of your body weight.
  • You have not had other weight-altering medicines (like steroids or antipsychotics) in the last 3 months.
  • You do not have uncontrolled thyroid problems, Cushing's syndrome, or cancer.
  • You do not have diabetes or a skin infection on your ear.
  • You are willing to have an MRI and are not pregnant or planning to become pregnant soon.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07630597Recruiting
Ear Nerve Stimulation to Help Weight Loss

This trial tests a non-invasive device that gently stimulates a nerve in your ear to help you lose weight after lifestyle changes haven't worked well enough. You wear the device on your ear for 12 weeks while continuing healthy habits.

Nanjing, Jiangsu
NCT07715929Not yet recruiting· Phase 4
Tirzepatide to prevent atrial fibrillation return after ablation in obesity

This trial tests whether a weight-loss medication called tirzepatide (given as a shot) helps prevent atrial fibrillation from coming back after a catheter ablation procedure. It is for people who have both obesity and atrial fibrillation, and it may help improve heart health by reducing weight and inflammation.

NCT07298915Not yet recruiting· Phase 3
Exercise and tirzepatide for better weight and health

This study tests whether combining a weight-loss medication called tirzepatide (also known as Mounjaro) with a supervised exercise program helps people lose weight and improve their overall health. You'll be in the study for about four months, and you'll get support and monitoring.

Charlottesville, Virginia
NCT07341971Not yet recruiting
Non-invasive nerve stimulation for central obesity

This trial tests a gentle, non-invasive nerve stimulation method (like a small device on the ear or neck) to see if it can help reduce central obesity—extra belly fat. It may help improve how your body burns fat and manages weight.

NCT06954844Enrolling by invitation
Study of ear stimulation for weight-related health in young adults

This study tests whether a gentle electrical stimulation of the ear (tVNS) can affect how the body handles weight. It aims to understand the brain and body changes related to obesity. Participants will receive the stimulation and undergo brain scans.

Bonn
NCT07866183Recruiting
New approaches to fat loss for class 1 obesity

This study tests new methods to help people with mild obesity (class 1) lose fat. It aims to find more effective and safe ways to support weight loss.

Moscow

Hear when a new Obesity & Overweight trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.